| Dr Michael David Most, MD | |
|
385 State Route 24 Ste 1b, Chester, NJ 07930-2908 | |
| (973) 404-9980 | |
| (973) 267-7295 |
| Full Name | Dr Michael David Most |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 23 Years |
| Location | 385 State Route 24 Ste 1b, Chester, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124238316 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 233702 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Morristown Medical Center | Morristown, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Elite Surgical Specialists | 1052745288 | 2 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today announced plans for a new manufacturing facility in China within the Suzhou Science and Technology Town - part of the company's strategy to aggressively expand its presence in the Asia-Pacific region.
Vismodegib, a new skin cancer drug for patients with advanced basal cell carcinoma tested by TGen, Virginia G. Piper Cancer Center at Scottsdale Healthcare and Mayo Clinic, is hailed as "the greatest advance in therapy yet seen" for advanced basal cell carcinoma in an editorial in the New England Journal of Medicine.
The New York Times: "The General Assembly became the first state legislature to approve a measure that bucks any effort by President Obama and Congress to carry out a national health care overhaul in individual states." Numerous Democrats joined the Republican majority to support the measure 80-17 in the House of Delegates (3/10).
Researchers at the Stanford University School of Medicine, in collaboration with BioParadox, Inc., have published data supporting the use of platelet-rich plasma as a promising biologic treatment for myocardial infarction.
For the first time, a malaria vaccine that uses the entire malaria parasite has proven safe and shown promise to produce a strong immune response in a clinical trial, according to a new study co-authored by researchers at the University of Maryland School of Medicine Center for Vaccine Development.
› Verified 4 days ago
| Entity Name | Summit Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942254347 PECOS PAC ID: 5395642276 Enrollment ID: O20031218000011 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today announced plans for a new manufacturing facility in China within the Suzhou Science and Technology Town - part of the company's strategy to aggressively expand its presence in the Asia-Pacific region.
Vismodegib, a new skin cancer drug for patients with advanced basal cell carcinoma tested by TGen, Virginia G. Piper Cancer Center at Scottsdale Healthcare and Mayo Clinic, is hailed as "the greatest advance in therapy yet seen" for advanced basal cell carcinoma in an editorial in the New England Journal of Medicine.
The New York Times: "The General Assembly became the first state legislature to approve a measure that bucks any effort by President Obama and Congress to carry out a national health care overhaul in individual states." Numerous Democrats joined the Republican majority to support the measure 80-17 in the House of Delegates (3/10).
Researchers at the Stanford University School of Medicine, in collaboration with BioParadox, Inc., have published data supporting the use of platelet-rich plasma as a promising biologic treatment for myocardial infarction.
For the first time, a malaria vaccine that uses the entire malaria parasite has proven safe and shown promise to produce a strong immune response in a clinical trial, according to a new study co-authored by researchers at the University of Maryland School of Medicine Center for Vaccine Development.
› Verified 4 days ago
| Entity Name | Elite Surgical Specialists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578110888 PECOS PAC ID: 1052745288 Enrollment ID: O20191223000065 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today announced plans for a new manufacturing facility in China within the Suzhou Science and Technology Town - part of the company's strategy to aggressively expand its presence in the Asia-Pacific region.
Vismodegib, a new skin cancer drug for patients with advanced basal cell carcinoma tested by TGen, Virginia G. Piper Cancer Center at Scottsdale Healthcare and Mayo Clinic, is hailed as "the greatest advance in therapy yet seen" for advanced basal cell carcinoma in an editorial in the New England Journal of Medicine.
The New York Times: "The General Assembly became the first state legislature to approve a measure that bucks any effort by President Obama and Congress to carry out a national health care overhaul in individual states." Numerous Democrats joined the Republican majority to support the measure 80-17 in the House of Delegates (3/10).
Researchers at the Stanford University School of Medicine, in collaboration with BioParadox, Inc., have published data supporting the use of platelet-rich plasma as a promising biologic treatment for myocardial infarction.
For the first time, a malaria vaccine that uses the entire malaria parasite has proven safe and shown promise to produce a strong immune response in a clinical trial, according to a new study co-authored by researchers at the University of Maryland School of Medicine Center for Vaccine Development.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael David Most, MD 1 Diamond Hill Road, Berkeley Heights, NJ 07922-2104 Ph: (908) 273-4300 | Dr Michael David Most, MD 385 State Route 24 Ste 1b, Chester, NJ 07930-2908 Ph: (973) 404-9980 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today announced plans for a new manufacturing facility in China within the Suzhou Science and Technology Town - part of the company's strategy to aggressively expand its presence in the Asia-Pacific region.
Vismodegib, a new skin cancer drug for patients with advanced basal cell carcinoma tested by TGen, Virginia G. Piper Cancer Center at Scottsdale Healthcare and Mayo Clinic, is hailed as "the greatest advance in therapy yet seen" for advanced basal cell carcinoma in an editorial in the New England Journal of Medicine.
The New York Times: "The General Assembly became the first state legislature to approve a measure that bucks any effort by President Obama and Congress to carry out a national health care overhaul in individual states." Numerous Democrats joined the Republican majority to support the measure 80-17 in the House of Delegates (3/10).
Researchers at the Stanford University School of Medicine, in collaboration with BioParadox, Inc., have published data supporting the use of platelet-rich plasma as a promising biologic treatment for myocardial infarction.
For the first time, a malaria vaccine that uses the entire malaria parasite has proven safe and shown promise to produce a strong immune response in a clinical trial, according to a new study co-authored by researchers at the University of Maryland School of Medicine Center for Vaccine Development.
› Verified 4 days ago
Dr. Carey Dolgin, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 385 Route 24, Suite 1b, Chester, NJ 07930 Phone: 908-809-2525 Fax: 877-796-3503 |